Novel dibenzocyclooctenes lignan and its preparation method and use

A technology of biphenyl cyclooctene lignan and medicinal plants, which is applied in the direction of pharmaceutical formulas, medical preparations containing active ingredients, organic active ingredients, etc.

Inactive Publication Date: 2005-07-06
肖培根 +1
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, no literature has been found to report that biphe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel dibenzocyclooctenes lignan and its preparation method and use
  • Novel dibenzocyclooctenes lignan and its preparation method and use
  • Novel dibenzocyclooctenes lignan and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: the preparation of formula I compound

[0033] Take Tiezandra propinqua (Wall.) Baill. 30Kg dry root and stem as raw material, reflux extraction with 95% ethanol three times, each time for 2 hours, concentrate to extract, suspend with appropriate amount of distilled water, let stand overnight, divide The layers yielded a water-insoluble fraction A and a water-soluble fraction B. The water-insoluble part was dissolved with an appropriate amount of ethanol, mixed with crude silica gel (100 mesh), eluted successively with petroleum ether, chloroform, ethyl acetate, and acetone, and then concentrated to extract. Partial extract of ethyl acetate (42g) was separated by silica gel (200-300 mesh) column chromatography, and 15 fractions were obtained by gradient elution with different ratios of petroleum ether to petroleum ether-acetone (1:2) successively. Fraction 11 After separation by Sephadex LH-20 chromatographic column with chloroform:methanol (1:1) as eluen...

Embodiment 3

[0034] Embodiment 3: the in vitro tumor inhibition test of formula I compound:

[0035] 1. Materials: Human acute promyelocytic leukemia cell line (HL-60), human liver cancer cell line (HepG2), and human oral squamous cell carcinoma cell line (KB) were purchased from ATCC, USA. Medium DMEM and fetal bovine serum were purchased from Gibico. MTT (3-(4,5-Dimethyiazol-2,5-diphenyl tetrazolium bromide) was purchased from Sigma.

[0036] 2. Tumor cell culture: HL-60, HepG2 and KB cells were respectively cultured in DMEM (containing 100u / ml Pemcillin and 100ug / ml Streptomycin) medium containing 10% FBS, collected well-grown cells and taken in the logarithmic growth phase Cell culture medium was prepared at a density of 1×10 5 The cell suspension of each cell / ml was uniformly inoculated in a 96-well culture plate, 100ul per well (that is, the number of cells per well was 10 4 pcs) at 5% CO 2 , 95% air, cultured in a cell incubator at 37°C for 24 hours. After the cells were completel...

Embodiment 4

[0050] Preparation of capsules

[0051] Formula I compound 20g

[0052] Lactose 80g

[0053] Magnesium Stearate 1.0%

[0054] 3% povidone ethanol solution appropriate amount

[0055] A total of 1000 capsules were made

[0056] Take prescription amount of compound of formula I and the prescription amount of lactose, mix evenly, add 3% povidone ethanol solution to make soft material, pass through 18 mesh sieve to make granules, dry at 50°C for 30-45 minutes, granulate, add magnesium stearate, mix Evenly, fill in No. 1 capsule. Each capsule contains 20mg of the compound.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to biphenyl cyclooctene lignin from root and stem of Schisandra propinqua(Wall.)Baill., its producing method and use. In vitro anti-tumor experiment shows that the compound has remarkable anti-tumor effect.

Description

Field of invention: [0001] The present invention relates to a new biphenylcyclooctene lignan isolated from the root and stem of Schisandra propinqua (Wall.) Baill., a medicinal plant of the genus Schisandra by means of phytochemical extraction and separation, a preparation method and the compound Application in the preparation of medicines for treating and / or preventing tumors. Background technique: [0002] Schisandraceae plants mainly contain lignans and triterpenes, among which lignans are the main bioactive components of Schisandraceae plants, and biphenylcyclooctene lignans are characteristic chemical components of Schisandraceae with unique skeletons. The stereochemistry is complex. In recent years, people have found through research that, in addition to the well-known functions of protecting the liver, reducing enzymes and regulating the central nervous system, lignans also have anti-lipid peroxidation, anti-tumor, anti-HIV and so on. So far, no literature has been ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/216A61P35/00C07C69/78
Inventor 肖培根陈士林陈四保许利嘉黄峰
Owner 肖培根
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products